Abbott Laboratories (ABT) Akcija Цена
Abbott Laboratories Цена
U poslednjih 19 godina prihod Abbott Laboratories rastao je 3,6 % godišnje i dostigao 44,33 Млрд USD. Zarada po akciji rasla je 6,6 % godišnje u poslednjih 19 godina. Za Abbott Laboratories neto marža od 14,7 % je pala u odnosu na 16,4 % pre nekoliko godina. Po današnjoj ceni dividendni prinos iznosi otprilike 2,17 %. Odnos isplate je oko 63 % dobiti. Dividenda je rasla 3,8 % godišnje u poslednjih 19 godina. Konsenzusna 12-mesečna ciljana cena za Abbott Laboratories je 121,00 USD, oko iznad kurs za 11,2 %. Od 33 analitičara 26 preporučuje kupovinu — ukupni konsenzus je Kupi.
Cena akcije Abbott Laboratories
Pristupite ovim podacima preko Eulerpool API-ja
100.000 zahteva/mes. besplatno · bez kartice
Abbott Laboratories poslovni model i analiza akcije
Često postavljana pitanja o akciji Abbott Laboratories
Abbott Laboratories is a renowned healthcare company with a strong business model focused on providing a diverse range of medical products, diagnostics, nutritional supplements, and pharmaceuticals. By combining technological advancements with innovative research, Abbott aims to enhance the quality of life for individuals worldwide. With a comprehensive portfolio spanning diverse healthcare sectors, including diagnostics, nutrition, diabetes care, medical devices, and branded generic pharmaceuticals, Abbott Laboratories strives to improve patient outcomes and deliver sustainable growth. Through its commitment to scientific excellence and dedication to meeting evolving healthcare needs, Abbott Laboratories has established itself as a trusted leader in the global healthcare industry.
Abbott Laboratories is primarily active in the healthcare industry.
The main competitors of Abbott Laboratories in the market are Johnson & Johnson, Pfizer, and Roche Holding AG.
Abbott Laboratories is a renowned American healthcare company, known for providing a diverse range of medical, pharmaceutical, and nutritional products. Founded in 1888 by Dr. Wallace C. Abbott, the company initially focused on producing pharmaceuticals, including the widely successful alkaloid-based pain reliever, Abbott's ABC Liniment. Over the years, Abbott Laboratories has expanded its portfolio, venturing into areas such as diagnostics, medical devices, and nutrition. The company's commitment to innovation is evident through breakthroughs like the development of the first HIV blood-screening test. Today, Abbott Laboratories continues to play a crucial role in improving health outcomes worldwide, with its cutting-edge technology and a focus on delivering quality healthcare solutions.
Abbott Laboratories has achieved several significant milestones throughout its history. One major milestone was the development and commercialization of the first-ever HIV blood screening test, which greatly contributed to safer transfusions and the prevention of the spread of HIV. Additionally, Abbott Laboratories introduced breakthrough medical devices, such as the FreeStyle® Libre system, a continuous glucose monitoring system for diabetes management. The company also played a crucial role in the fight against COVID-19 by developing rapid diagnostic tests for the virus. Furthermore, Abbott Laboratories has consistently been recognized for its commitment to innovation and sustainability, making it a leading healthcare company globally.
Abbott Laboratories is primarily present in multiple countries and regions worldwide. The company operates in more than 160 countries, including the United States, Canada, Europe, Asia-Pacific, Latin America, and the Middle East. With a strong global footprint, Abbott Laboratories has established itself as a leading healthcare company in various markets, delivering innovative medical products, diagnostics, nutritionals, and pharmaceuticals to improve people's health and well-being.
Abbott Laboratories is committed to its core values of putting patients first, serving customers with innovative solutions, and operating with integrity in all aspects of its business. The company's corporate philosophy centers around improving life through the development of groundbreaking technologies and products. Abbott Laboratories prides itself on its dedication to delivering reliable healthcare solutions, fostering collaboration with healthcare professionals, and investing in research and development to address unmet medical needs. With a focus on providing high-quality and accessible healthcare options, Abbott Laboratories strives to create positive impacts in communities worldwide through its diverse portfolio of medical devices, diagnostics, nutrition, and pharmaceutical products.
Analitičari trenutno postavljaju prosečnu ciljanu cenu 123,64 USD za akciju Abbott Laboratories (medijana: 121,00 USD), što znači +13,7 % u odnosu na poslednju cenu. Konsenzus se zasniva na 33 ocena.
33 analitičara trenutno ocenjuje akciju Abbott Laboratories: 26 preporučuje kupovinu, 7 držanje i 0 prodaju. Za 2026 analitičari očekuju da Abbott Laboratories ostvari prihod 49,99 Млрд USD i zaradu po akciji 5,52 USD.
Po trenutnom kursu akcija Abbott Laboratories kotira 97,17 EUR (108,78 USD).
Akcija Abbott Laboratories (ABT) kotira na 9 berze, uključujući: NYSE (ABT), London (0Q15.L), SIX (Zürich) (ABT.SW), XETRA (ABL.DE), Frankfurt (ABL.F), München (ABL.MU), Düsseldorf (ABL.DU), Hamburg (ABL.HM).
Abbott Laboratories is a global company specializing in the development, manufacturing, and marketing of health products and services. Its business model is divided into different divisions that focus on the needs of patients, doctors, and healthcare systems. The divisions of Abbott Laboratories include Diagnostics, Medical Devices, Nutrition, and Pharmaceutical. The company aims to continuously develop innovative technologies and products to improve healthcare, and it offers a wide range of services and support programs for patients. Abbott Laboratories has established a strong market position and global presence in over 160 countries since its establishment in 1888. It also pursues a successful acquisition strategy to expand its product portfolio, such as the acquisition of St. Jude Medical in 2017 to enhance its cardiovascular products and services. Overall, Abbott Laboratories aims to improve healthcare and meet the needs of patients, doctors, and healthcare systems through its comprehensive strategy focused on developing innovative products, expanding into new markets, and increasing efficiency.
očekivana prihod od Abbott Laboratories je 49,99 Млрд USD. Ova cifra je zasnovana na trenutnim finansijskim podacima i odražava poslovne rezultate preduzeća.
očekivana dobit od Abbott Laboratories je 9,64 Млрд USD. Neto dobit pokazuje profitabilnost preduzeća nakon odbitka svih troškova.
Odnos cene i zarade (KGV) za Abbott Laboratories je trenutno 19,70. KGV poredi sadašnju cenu akcije sa zaradom po akciji i pomaže investitorima da procene valuaciju akcije Abbott Laboratories.
Odnos cene i prihoda (KUV) za Abbott Laboratories je trenutno 3,80. KUV poredi tržišnu kapitalizaciju sa godišnjim prihodima i služi kao metrika valuacije za akciju Abbott Laboratories.
Eulpool score kvaliteta za Abbott Laboratories je 6/10.
ISIN za Abbott Laboratories je US0028241000. ISIN (International Securities Identification Number) je globalno jedinstveni identifikator za hartije od vrednosti.
WKN za Abbott Laboratories je 850103. WKN (Wertpapierkennnummer) je šestocifreni nemački broj za identifikaciju hartija od vrednosti.
Ticker za Abbott Laboratories je ABT. Simbol tikera se koristi za trgovinu akcijama Abbott Laboratories na berzanskom tržištu.
Abbott Laboratories акција
Abbott Laboratories Peer grupa
Abbott Laboratories Тикер
Abbott Laboratories FIGI
Sve ključne metrke i detaljne analize Abbott Laboratories u dubinskoj analizi
Naša analiza akcija za akciju Abbott Laboratories uključuje važne finansijske pokazatelje kao što su prihod, profit, P/E odnos, P/S odnos, EBIT, kao i informacije o dividendama. Takođe, razmatramo aspekte poput akcija, tržišne kapitalizacije, dugova, kapitala i obaveza kompanije Abbott Laboratories. Ako tražite detaljnije informacije o ovim temama, na našim podstranicama vam nudimo opsežne analize: